Correlation Between BiOasis Technologies and Gain Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BiOasis Technologies and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BiOasis Technologies and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between biOasis Technologies and Gain Therapeutics, you can compare the effects of market volatilities on BiOasis Technologies and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BiOasis Technologies with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BiOasis Technologies and Gain Therapeutics.

Diversification Opportunities for BiOasis Technologies and Gain Therapeutics

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between BiOasis and Gain is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding biOasis Technologies and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and BiOasis Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on biOasis Technologies are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of BiOasis Technologies i.e., BiOasis Technologies and Gain Therapeutics go up and down completely randomly.

Pair Corralation between BiOasis Technologies and Gain Therapeutics

Assuming the 90 days horizon biOasis Technologies is expected to generate 4.69 times more return on investment than Gain Therapeutics. However, BiOasis Technologies is 4.69 times more volatile than Gain Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Gain Therapeutics is currently generating about 0.0 per unit of risk. If you would invest  12.00  in biOasis Technologies on August 29, 2024 and sell it today you would lose (11.99) from holding biOasis Technologies or give up 99.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

biOasis Technologies  vs.  Gain Therapeutics

 Performance 
       Timeline  
biOasis Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days biOasis Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, BiOasis Technologies is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders.
Gain Therapeutics 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Gain Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Gain Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

BiOasis Technologies and Gain Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BiOasis Technologies and Gain Therapeutics

The main advantage of trading using opposite BiOasis Technologies and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BiOasis Technologies position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.
The idea behind biOasis Technologies and Gain Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope